Loading...
BioSig Technologies, Inc.
BSGM•NASDAQ
HealthcareMedical - Devices
$7.34
$1.60(27.87%)
BioSig Technologies, Inc. (BSGM) Financial Performance & Statements
Review BioSig Technologies, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
122.22%
↑ 122.22%
Operating Income Growth
54.89%
↑ 54.89%
Net Income Growth
64.43%
↑ 64.43%
Operating Cash Flow Growth
72.52%
↑ 72.52%
Operating Margin
-31522.50%
↓ 31522.50%
Gross Margin
-635.00%
↓ 635.00%
Net Profit Margin
-25832.50%
↓ 25832.50%
ROE
709.93%
↑ 709.93%
ROIC
886.71%
↑ 886.71%
BioSig Technologies, Inc. (BSGM) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for BioSig Technologies, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $13000.00 | $0.00 | $13000.00 | $14000.00 |
| Cost of Revenue | $167000.00 | $0.00 | $49000.00 | $78000.00 |
| Gross Profit | -$154000.00 | $0.00 | -$36000.00 | -$64000.00 |
| Gross Profit Ratio | -$11.85 | $0.00 | -$2.77 | -$4.57 |
| R&D Expenses | $96000.00 | $156000.00 | $342000.00 | $238000.00 |
| SG&A Expenses | $1.07M | $2.76M | $4.91M | $2.88M |
| Operating Expenses | $1.20M | $2.95M | $5.30M | $3.12M |
| Total Costs & Expenses | $1.20M | $2.95M | $5.30M | $3.20M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $5000.00 | $3000.00 |
| Depreciation & Amortization | $30000.00 | $31000.00 | $49000.00 | $78000.00 |
| EBITDA | -$1.22M | -$2.92M | -$3.86M | -$3.33M |
| EBITDA Ratio | -$93.54 | -$296.69 | -$238.14 | |
| Operating Income | -$1.18M | -$2.95M | -$5.29M | -$3.18M |
| Operating Income Ratio | -$91.00 | -$407.08 | -$227.43 | |
| Other Income/Expenses (Net) | $84000.00 | $1.04M | $1.38M | -$231000.00 |
| Income Before Tax | -$1.10M | -$1.91M | -$3.91M | -$3.42M |
| Income Before Tax Ratio | -$84.54 | -$300.85 | -$243.93 | |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $122000.00 |
| Net Income | -$1.10M | -$1.91M | -$3.92M | -$3.40M |
| Net Income Ratio | -$84.54 | -$301.38 | -$243.00 | |
| EPS | -$0.008 | -$0.01 | -$0.03 | -$0.03 |
| Diluted EPS | -$0.008 | -$0.01 | -$0.03 | -$0.03 |
| Weighted Avg Shares Outstanding | $140.42M | $159.84M | $129.16M | $98.56M |
| Weighted Avg Shares Outstanding (Diluted) | $140.42M | $162.009M | $129.16M | $98.56M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan